ENTOD Pharma Secures Patent for Insulin Eye Drop
Published
AI-generated summary of the coverage listed below: ENTOD Pharma has secured a patent for its insulin eye drop. The patent covers the formulation and delivery method of the drug. The company plans to advance the product toward clinical trials.
Covered by 1 outlet across the spectrum: 0% left, 100% center, 0% right.
Who is covering this story
- Center (1): The New Indian Express
Sources
- ENTOD Pharma secures patent for its insulin eye drop — The New Indian Express (center)